Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
-- Caribou met with the FDA and reached alignment on a pivotal trial in 2L LBCL with CB-010 versus a...
Read more-- Caribou met with the FDA and reached alignment on a pivotal trial in 2L LBCL with CB-010 versus a...
Read moreData Support 14 Days On/14 Days Off as Optimal Dosing Schedule; CFT7455 is Well Tolerated with Promising Signs of Anti-Myeloma...
Read moreALHAMBRA, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq: EMKR), the world’s largest independent provider of inertial navigation...
Read moreExpert panel to explore key trends in healthcare cost management, AI in healthcare, and elevating benefits literacy among a diverse...
Read moreMEMPHIS, Tenn., Dec. 12, 2023 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE:AZO) announced it will hold its Annual Meeting of Stockholders...
Read moreProduct Philanthropy Nonprofit Moves from #6 to #2 in 40th Anniversary YearAlexandria, VA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Good360,...
Read moreMINNEAPOLIS, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Verizon announces a $100,000 award to the Minnesota Technology Association (MnTech) for its...
Read moreNNS Habitat for Humanity Dedication 2023 A dedication ceremony and ribbon cutting was held Tuesday, December 12, 2023 for the...
Read moreLeading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech...
Read moreGlobal Liver Institute’s Second Edition “Global State of Liver Health” Report Reveals Promising Opportunities Global State of Liver Health Report...
Read more